ImmunityBio secures US patent portfolio covering ANKTIVA combination therapy through to 2035
Artivion completes acquisition of Endospan following FDA approval of NEXUS Aortic Arch System
AstraZeneca wins US approval for Baxfendy as first aldosterone synthase inhibitor for hypertension
CelLBxHealth partners with AdventHealth on cancer monitoring studies
GSK's Arexvy gains expanded approval in Japan for at-risk adults aged 18-49
Atisama Therapeutics reports progress in Phase 1 study of RB042
Tenaya Therapeutics reports interim RIDGE-1 data showing reduced arrhythmia burden with TN-401
SN BioScience reports first patient dosed in global Phase 1b/2 clinical trial of SNB-101
Apotex announces commercial launch of Apo-Semaglutide Injection in Canada
US FDA approves Datar Cancer Genetics' comprehensive genomic profiling assay for solid tumours
Intensity Therapeutics receives Cancer Treatment Technology Innovator of the Year award
AstraZeneca reports survival gains in Phase III bladder cancer trial
Creatv Bio opens CLIA-certified laboratory in Monmouth Junction, NJ
SOPHiA GENETICS and Synnovis partner to expand NHS liquid biopsy testing